Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.
This study is currently recruiting participants.
Study NCT00588406 Information provided by North Shore Long Island Jewish Health System
First Received: December 21, 2007 Last Updated: July 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Asthma
Additional conditions recognized in this trial
Emergencies
More general conditions related to this trial
Bronchial Diseases
Disease Attributes
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Lung Diseases
Lung Diseases, Obstructive
Pathologic Processes
Respiratory Hypersensitivity
Respiratory Tract Diseases
Interventions listed in this trial
Budesonide
albuterol
Ipratropium bromide
Prednisone
Additional drug interventions recognized in this trial
Ipratropium
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Agonists
Adrenergic beta-Agonists
Anti-Asthmatic Agents
Anti-Inflammatory Agents
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Autonomic Agents
Bronchodilator Agents
Cholinergic Agents
Cholinergic Antagonists
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Respiratory System Agents
Therapeutic Uses
Tocolytic Agents
Sponsors listed in this trial
North Shore Long Island Jewish Health System
AstraZeneca
Jacobi Medical Center
Nassau University Medical Center
Back to top of Main Content
